In HER2-positive breast cancer, elevated expression of PAK5 promotes m6A modification of lncRNA MALAT1 through phosphorylation of the methyltransferase METTL14 at serine 399, thereby stabilizing MALAT1 RNA level. The gene discussed is PAK5; the disease is breast carcinoma.